Cargando…
Reduced tumorigenicity and drug resistance through the downregulation of octamer-binding protein 4 and Nanog transcriptional factor expression in human breast stem cells
Breast cancer is the most common type of malignancy among females. Previous studies examining breast cancer tissue have demonstrated the presence of stem cells, and have detected octamer-binding protein 4 (Oct4) and Nanog transcription factor expression. In the present study, breast cancer stem cell...
Autores principales: | HUANG, ZHENG-JIE, YOU, JUN, LUO, WEI-YUAN, CHEN, BAI-SHENG, FENG, QING-ZHAO, WU, BING-LIN, JIANG, LONG, LUO, QI |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4270319/ https://www.ncbi.nlm.nih.gov/pubmed/25405855 http://dx.doi.org/10.3892/mmr.2014.2972 |
Ejemplares similares
-
Cell cycle and pluripotency: Convergence on octamer-binding transcription factor 4
por: She, Shiqi, et al.
Publicado: (2017) -
Analysis of octamer-binding transcription factor-4 expression in oral leukoplakia
por: Tegginamani, Anand Siddappa, et al.
Publicado: (2020) -
Expression of Recombinant Human Octamer-Binding Transcription Factor 4 in Rice Suspension Cells
por: Huang, Li-Fen, et al.
Publicado: (2021) -
miR-150 Suppresses the Proliferation and Tumorigenicity of Leukemia Stem Cells by Targeting the Nanog Signaling Pathway
por: Xu, Dan-dan, et al.
Publicado: (2016) -
Effects of lentiviral infection of mesenchymal stem cells on the expression of octamer transcription factor 4
por: CHANG, JING, et al.
Publicado: (2014)